Chill Brands Group PLC AI Stock Analysis
Want to see GB:CHLL full AI Analyst Report?
Chill Brands Group PLC (CHLL) AI Stock Analysis
Chill Brands Group PLC
(LSE:CHLL)
The overall score is severely depressed by the company's precarious financial state, marked by negative equity and consistent cash burn. A persistent technical downtrend and a meaningless negative P/E ratio further confirm the lack of fundamental or market support, making this a high-risk investment.
Chill Brands Group PLC (CHLL) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 836.68K
- Dividend Yield
- ―
- Average Volume (3M)
- 21.19K
- Price to Earnings (P/E)
- -0.0
- Beta (1Y)
- 0.02
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- UK
- Employees
- 11
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Chill Brands Group PLC Business Overview & Revenue Model
Company Description
Chill Brands Group PLC, established in 2014, operates from its headquarters in London, United Kingdom. The company focuses on the innovation, manufacturing, and distribution of cannabidiol (CBD) consumer items and other lifestyle products across the...
How the Company Makes Money
Chill Brands Group PLC makes money primarily by selling nicotine-alternative products (such as vaping/e-cigarette products) through wholesale/distribution and retail channels where it operates or has access to market. Revenue is generated when the co...
Chill Brands Group PLC Financial Statement Overview
Summary
Financial health is critically weak. Persistent operating losses, negative gross margins, negative shareholders' equity, and deep cash burn indicate severe solvency and liquidity risks. Narrowing losses provide a marginal positive but are insufficient to offset the fundamental instability.
Income Statement
15Very NegativeBalance Sheet
12Very NegativeCash Flow
10Very Negative| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 359.35K | 1.91M | 305.70K | 82.84K | 624.19K | 320.88K |
| Gross Profit | -172.69K | 472.81K | -395.58K | -206.86K | -778.81K | -40.64K |
| EBITDA | -1.68M | -2.75M | -2.88M | -3.81M | -5.46M | -4.78M |
| Net Income | -1.97M | -3.37M | -3.30M | -4.29M | -5.71M | -4.85M |
Balance Sheet | ||||||
| Total Assets | 2.14M | 5.27M | 2.13M | 6.14M | 3.26M | 1.76M |
| Cash, Cash Equivalents and Short-Term Investments | 99.96K | 1.32M | 30.95K | 3.77M | 420.05K | 333.18K |
| Total Debt | 2.69M | 1.81M | 1.74M | 4.72M | 337.02K | 80.42K |
| Total Liabilities | 3.37M | 2.69M | 2.86M | 5.26M | 1.72M | 1.99M |
| Stockholders Equity | -1.23M | 2.57M | -731.00K | 878.67K | 1.54M | -224.18K |
Cash Flow | ||||||
| Free Cash Flow | -1.38M | -4.19M | -1.22M | -3.15M | -5.61M | -985.99K |
| Operating Cash Flow | -1.38M | -4.19M | -1.22M | -2.51M | -4.96M | -984.64K |
| Investing Cash Flow | -4,489 | 87.03K | -982 | -639.19K | -644.64K | 300.54K |
| Financing Cash Flow | 1.16M | 1.74M | -66.89K | 6.61M | 5.64M | 623.25K |
Chill Brands Group PLC Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CHLL, the sentiment is Negative. The current price of 1.60 is below the 20-day moving average (MA) of 1.64, below the 50-day MA of 1.73, and below the 200-day MA of 3.11, indicating a bearish trend. The MACD of -0.04 indicates Negative momentum. The RSI at 0.10 is Positive, neither overbought nor oversold. The STOCH value of 97.92 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:CHLL.
Chill Brands Group PLC Peers Comparison
Overall Rating
GB:VLG65Neutral
GB:HLN63Neutral
GB:PXS45Neutral
GB:STX43Neutral
GB:CHLL40Underperform
GB:AGY38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 65Neutral | GBP 82.26M | 15.82 | 7.82% | ― | ― | ― | |
| 63Neutral | GBP 30.09B | 18.92 | 9.89% | 1.34% | 1.21% | 8.33% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | GBP 20.06M | -85.50 | -44.68% | ― | -2.14% | 0.00% | |
| 43Neutral | GBP 32.76M | -4.09 | 64.57% | ― | 36.19% | 60.75% | |
| 40Underperform | GBP 836.68K | -0.00 | 233.76% | ― | ― | ― | |
| 38Underperform | GBP 88.66M | -1.59 | 1684.19% | ― | 8.77% | -7.14% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:CHLL | Chill Brands Group PLC | 1.60 | -8.15 | -83.59% | |
| GB:AGY | Allergy Therapeutics | 1.23 | -8.13 | -86.90% | |
| GB:PXS | Provexis plc | 0.70 | 0.10 | 16.14% | |
| GB:STX | Shield Therapeutics | 3.05 | -3.70 | -54.81% | |
| GB:VLG | Venture Life | 68.50 | 10.00 | 17.09% | |
| GB:HLN | Haleon PLC | 341.90 | -27.81 | -7.52% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 26, 2026
